Introduction
Stem cells are the body's master cells — the raw materials from which all other specialized cells are generated. Under the right conditions, stem cells divide to form daughter cells that either become new stem cells (self-renewal) or differentiate into specialized cells with specific functions such as blood cells, brain cells, heart muscle cells, or bone cells.
No other cell in the body has this natural ability to generate new cell types. This unique property makes stem cells profoundly important for medicine, offering potential pathways to repair damaged tissues, replace dysfunctional cells, and support the body's natural healing processes.
In this guide, we break down the fundamentals of stem cell biology in plain language — what they are, where they come from, how they work, and why they are at the center of modern regenerative medicine.
The Two Defining Properties of Stem Cells
What makes a stem cell different from every other cell in your body comes down to two properties: self-renewal and differentiation.
Self-renewal means a stem cell can divide and produce more stem cells identical to itself. This is how the body maintains its pool of regenerative cells over a lifetime. Unlike most cells, which have a limited number of divisions before they age and die, stem cells can replicate extensively.
Differentiation is the process by which a stem cell transforms into a specialized cell type. When a stem cell differentiates, it follows a specific developmental pathway to become a muscle cell, nerve cell, blood cell, or any of the 200+ cell types in the human body. This process is guided by signals from the cell's environment — growth factors, cytokines, and physical cues from surrounding tissues.
Together, these two properties mean that stem cells serve as both a reserve force (self-renewal) and a repair crew (differentiation) for the body's tissues and organs.
Types of Stem Cells
Not all stem cells are the same. They vary in their potency (how many cell types they can become) and their source (where they come from in the body).
Embryonic stem cells (ESCs) are derived from early-stage embryos and are pluripotent — they can become virtually any cell type in the body. While scientifically powerful, their use raises ethical considerations and they carry risk of tumor formation (teratomas).
Adult stem cells (also called somatic stem cells) exist in small numbers in most tissues and organs. They are typically multipotent, meaning they can produce several related cell types. Examples include hematopoietic stem cells in bone marrow (which produce blood cells) and neural stem cells in the brain.
Induced pluripotent stem cells (iPSCs) are adult cells that have been genetically reprogrammed to return to a stem-cell-like state. Discovered in 2006 by Shinya Yamanaka (who won the Nobel Prize for this work), iPSCs hold enormous research potential but are not yet widely used in clinical treatments.
Mesenchymal stem cells (MSCs) are a type of adult stem cell found in bone marrow, adipose (fat) tissue, and perinatal tissues like umbilical cord and Wharton's Jelly. MSCs are the most commonly used stem cell in clinical regenerative medicine today due to their safety profile, ease of isolation, and powerful therapeutic properties.
Am I a Candidate for Stem Cell Therapy?
Take our 2-minute quiz to get a personalized candidacy assessment based on your condition, treatment history, and goals.
Where Do Therapeutic Stem Cells Come From?
In regenerative medicine, the source of stem cells significantly affects their therapeutic potential. The three primary clinical sources are bone marrow, adipose tissue, and perinatal tissues.
Bone marrow-derived MSCs were the first to be used clinically and remain well-studied. However, collecting them requires a bone marrow aspiration procedure, and the cells' potency declines significantly with the donor's age.
Adipose-derived MSCs are harvested through liposuction. They are abundant and relatively easy to collect, but like bone marrow cells, their quality depends on the donor's age and health status.
Perinatal MSCs, sourced from umbilical cord tissue (specifically Wharton's Jelly), placenta, or amniotic fluid, represent the youngest and most potent clinical-grade MSCs available. Because they are collected from tissue that would otherwise be discarded after a healthy birth, there are no ethical concerns. These cells have longer telomeres, higher proliferative capacity, and stronger immunomodulatory properties compared to adult-derived sources.
At BioGenesis, we exclusively use Wharton's Jelly-derived MSCs because they combine maximum regenerative potential with an excellent safety profile and zero ethical controversy.
How Do Stem Cells Actually Help the Body Heal?
A common misconception is that stem cells work by simply replacing damaged cells one-for-one. While differentiation plays a role, the primary therapeutic mechanism of MSCs is paracrine signaling — the release of bioactive molecules that influence surrounding cells and tissues.
When MSCs are introduced into the body, they release a rich cocktail of growth factors, cytokines, chemokines, and extracellular vesicles (including exosomes). These molecules perform several critical functions:
Anti-inflammatory action: MSCs release factors like IL-10, TGF-beta, and PGE2 that calm excessive inflammation, which is the root driver of many chronic diseases.
Tissue repair signaling: Growth factors like VEGF, HGF, and FGF promote blood vessel formation, tissue regeneration, and cellular repair in damaged areas.
Immune modulation: MSCs can regulate both innate and adaptive immune responses, making them valuable for autoimmune conditions where the immune system attacks the body's own tissues.
Anti-fibrotic effects: MSCs help prevent and reduce scar tissue formation, supporting functional tissue regeneration instead of fibrotic repair.
This paracrine mechanism means that even a relatively small number of stem cells can have significant therapeutic effects by orchestrating the body's own repair processes — like a conductor directing a symphony of healing.
The Current State of Stem Cell Medicine
Stem cell research is one of the fastest-growing fields in biomedical science. As of 2026, over 10,000 clinical trials involving stem cells have been registered worldwide, with MSCs being the most frequently studied cell type.
Conditions being actively researched include osteoarthritis, heart disease, neurological disorders (MS, Parkinson's, Alzheimer's), autoimmune diseases, diabetes, liver disease, kidney disease, and many more.
While stem cell therapy is not a cure-all, the scientific evidence supporting MSC therapy for specific conditions continues to grow. The key is understanding what stem cells can and cannot do, working with qualified medical teams, and having realistic expectations about outcomes.
Regenerative medicine represents a fundamental shift in how we approach disease — moving from managing symptoms to supporting the body's innate capacity to repair and regenerate. Stem cells are at the very center of this transformation.
Key Takeaways
- 1Stem cells are unique because they can both self-renew and differentiate into specialized cell types
- 2MSCs (mesenchymal stem cells) are the most commonly used stem cells in clinical regenerative medicine
- 3Wharton's Jelly MSCs offer the highest potency with no ethical concerns
- 4Stem cells primarily work through paracrine signaling — releasing healing molecules that orchestrate the body's repair processes
- 5Over 10,000 clinical trials worldwide are studying stem cell therapies as of 2026
- 6Stem cell therapy is not a cure-all, but offers genuine therapeutic potential for many conditions when administered by qualified medical teams
Frequently Asked Questions About What Are Stem Cells?
MSCs, particularly those derived from Wharton's Jelly, have an excellent safety profile documented across thousands of clinical studies. They do not carry the tumor-formation risks associated with embryonic stem cells. Side effects are typically limited to mild, temporary reactions at the infusion site. However, it is critical to receive treatment from a qualified, regulated medical facility.
No. PRP is derived from your own blood and contains growth factors from platelets, but it does not contain living stem cells. Stem cell therapy introduces actual living cells with the ability to differentiate, self-renew, and release a much broader range of therapeutic molecules. They work through different mechanisms, though some protocols use both complementarily.
No responsible medical professional claims stem cells can cure diseases. MSC therapy is a supportive and regenerative treatment that may help manage symptoms, slow disease progression, support tissue repair, and improve quality of life. Outcomes depend on the condition being treated, its severity, and individual patient factors.
Wharton's Jelly MSCs are derived from newborn tissue, giving them maximum regenerative potential, longer telomeres, and higher proliferative capacity. They have stronger immunomodulatory properties, carry minimal risk of immune rejection, and are collected from tissue discarded after healthy births — avoiding the invasive bone marrow aspiration procedure required for bone marrow-derived cells.
Was this article helpful?
Not Sure If You're a Candidate?
Take our 2-minute quiz to get a personalized candidacy assessment, or apply directly to speak with our medical team.